Does the Level of Prostate Cancer Risk Affect Cancer Prevention with Finasteride?
- 31 May 2008
- Vol. 71 (5) , 854-857
- https://doi.org/10.1016/j.urology.2008.01.025
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Finasteride and High-Grade Prostate Cancer in the Prostate Cancer Prevention TrialJNCI Journal of the National Cancer Institute, 2007
- Finasteride Improves the Sensitivity of Digital Rectal Examination for Prostate Cancer DetectionJournal of Urology, 2007
- Effect of Finasteride on the Sensitivity of PSA for Detecting Prostate CancerJNCI Journal of the National Cancer Institute, 2006
- Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention TrialJNCI Journal of the National Cancer Institute, 2006
- Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per MilliliterNew England Journal of Medicine, 2004
- The Influence of Finasteride on the Development of Prostate CancerNew England Journal of Medicine, 2003
- Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trialBMJ, 2000
- Combined finasteride and flutamide therapy in men with advanced prostate cancerUrology, 1996
- Treatment with finasteride following radical prostatectomy for prostate cancerUrology, 1995
- Finasteride dose-dependently reduces the proliferation rate of the LnCap human prostatic cancer cell line in vitroUrology, 1995